InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Shukla Sath, Chief Financial Officer. Officer active across 1 company, notably Spero Therapeutics, Inc.. Aggregated, 10 filings have been logged. Breakdown: 0 buy · 4 sells. Total volume traded: €29k. Activity tracked since 26 August 2021. The latest transaction was filed on 3 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Shukla Sath
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
751,407 shares0Common StockSEC:0000950170-25-014850:0
2,757 shares@ US$1.3511.5% of flowCommon StockSEC:0000950170-24-101993:0
14,800 shares@ US$1.3262.5% of flowCommon StockSEC:0000950170-24-092170:0
679,501 shares0Common StockSEC:0000950170-24-011487:0
1,854 shares@ US$1.267.4% of flowCommon StockSEC:0000950170-23-045441:0
266,000 shares0Common StockSEC:0000950170-23-037973:0
265,957 shares0Common StockSEC:0000899243-23-003945:0
6,017 shares@ US$0.893818.5% of flowCommon StockSEC:0000899243-22-030087:0
38,014 shares0Common StockSEC:0000899243-22-004593:0
24,067 shares0Common StockSEC:0000899243-21-034498:0
10 of 10 declarations
About Shukla Sath
Shukla Sath is Chief Financial Officer. He has 10 filings in total, and within the 10 sampled recent filings, the recorded transactions run from 2021-08-30 to 2025-02-05, with 0 in purchases and 28968 in sales, mainly at Spero Therapeutics, Inc. The modal transaction nature is Attribution.
